Vicki Moore, PhD

Contributing Writer https://www.oncologynurseadvisor.com

Vicki Moore, PhD, is a freelance medical writer for Hematology Advisor. Vicki received her PhD in biology from Arizona State University, where her research emphasized molecular biology, biochemistry, and metabolic engineering. She also has experience with predictive analytics and is intrigued by its applications to medicine. Vicki has been a medical writer, focusing on areas of hematology and oncology, among other specialties, since late 2017. You can find her on Linkedin at linkedin.com/in/vicki-moore-93950913

All articles by Vicki Moore, PhD

Cryopreserved platelets may reduce bleeding in patients with thrombocytopenia.

General Oncology

Assay to Detect Antibodies to SARS-CoV-2 in Human Serum or Plasma

Vicki Moore, PhD

April 8, 2020

The researchers found that samples from patients with COVID-19 showed strong reactivity to both the full-length S protein and the RBD.

Leukemia

Outpatient Induction Chemotherapy for Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Vicki Moore, PhD

April 2, 2020

With adequate support from a multidisciplinary care team, outpatient induction chemotherapy was safe for these patients.

Chemotherapy drugs can require special handling.

General Oncology

Hazardous Drug Exposure Among Oncology Nurses During Spills

Vicki Moore, PhD

March 31, 2020

In an effort to gather data on hazardous drug exposure, researchers surveyed oncology nurses regarding spills and use of personal protective equipment at 12 participating academic infusion centers.

CD33 positivity and MPC-1 negativity appear to be associated with worse outcomes in patients with multiple myeloma treated with bortezomib as induction therapy.

Lymphoma

Induction in Transplant-Eligible Mantle Cell Lymphoma With Rituximab and Cytarabine Added to Rituximab and Bendamustine

Vicki Moore, PhD

March 31, 2020

The researchers found that high rates of remission could be achieved with induction therapy using rituximab/bendamustine in addition to rituximab/cytarabine.

Lymphoma

Brentuximab Vedotin With Bendamustine for Patients With Refractory or Multiple Relapsed Classic Hodgkin Lymphoma

Vicki Moore, PhD

March 30, 2020

A retrospective analysis found encouraging evidence for the use of BvB in treatment of RR-cHL.

Men using portable spray rig on tree and grass environment.

Lymphoma

Glyphosate Exposure and Relative Risks of Non-Hodgkin Lymphoma or Multiple Myeloma

Vicki Moore, PhD

March 27, 2020

Researchers conducted a meta-analysis of 7 studies involving NHL and 3 focused on MM to determine the role of occupational exposure to glyphosate in terms of risk.

Side-Effect Management

One Hospital’s Approach to Addressing the Heparin Shortage

Vicki Moore, PhD

March 26, 2020

A conservation and waste reduction approach was used to reduce heparin use at a major medical center.

A nurse confers with a patient about upcoming treatment.

General Oncology

Fast-Track Clinic, Communications Reduce Infusion Clinic Wait Times

Vicki Moore, PhD

March 24, 2020

After identifying bottlenecks at a VA hospital infusion clinic in Alabama, better communications and establishing a fast-track clinic for some patients led to a 23% reduction in infusion clinic wait times.

General Oncology

Management for Depression Symptoms Lacking in Patients With a Cancer Diagnosis

Vicki Moore, PhD

March 19, 2020

Antidepressant treatment, social work referral, and psychological assessment are shown to improve depression symptoms in patients with a cancer diagnosis.

Creating a treatment plan for an older patient.

Lung Cancer

Enhanced Recovery After Surgery Program Improves Outcomes for Elderly With Lung Cancer

Vicki Moore, PhD

March 17, 2020

Surgical recovery program has the potential to improve postsurgical outcomes for older patients with lung cancer.

Next post in Lung Cancer